Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine

Karl B Scheidweiler1, Bruce Ladenheim, Jean Lud Cadet

  • 1Chemistry and Drug Metabolism, Intramural Research Program, National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard Suite 200, Room 05A-721, Baltimore, MD 21224, USA.

Neurotoxicity Research
|October 24, 2009
PubMed

Insights

Multidrug resistance protein 1a (MDR1a) influences methylenedioxymethamphetamine (MDMA) effects on mouse dopamine systems. MDR1a knockout mice show altered dopamine turnover after MDMA, suggesting a role in neurotoxicity.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Multidrug resistance protein 1a (MDR1a) is implicated in the neurotoxic effects of methylenedioxymethamphetamine (MDMA).
  • Previous studies suggest MDR1a influences dopamine (DA) and dopamine transporter levels post-MDMA exposure.

Purpose of the Study:

  • To investigate the acute effects of MDMA on the nigrostriatal dopamine system in MDR1a wild-type and knockout mice.
  • To determine the role of MDR1a in the immediate handling of MDMA and its impact on dopamine turnover within 0-24 hours.

Main Methods:

  • Acute MDMA administration to mdr1a wild-type (mdr1a +/+) and knockout (mdr1a -/-) mice at varying doses.
  • Measurement of 3,4-dihydroxyphenylacetic acid (DOPAC)/DA ratios in striatal tissue over 0-24 hours.
  • Quantification of striatal MDMA and metabolite concentrations using gas chromatography-mass spectrometry.

Main Results:

  • Significant interactions between mouse strain, time, and dose were observed for DOPAC/DA ratios.
  • MDMA increased DOPAC/DA ratios in mdr1a +/+ mice but decreased them in mdr1a -/- mice within the first 3 hours.
  • Twenty-four hours post-MDMA, mdr1a +/+ mice exhibited a 600% increase in DOPAC/DA ratios, while mdr1a -/- mice showed no change.
  • Striatal MDMA and metabolite levels were similar between strains, ruling out altered drug transport.

Conclusions:

  • MDR1a significantly modulates the acute effects of MDMA on dopamine turnover in the nigrostriatal system.
  • The observed differences in dopamine turnover suggest MDR1a influences MDMA neurotoxicity, potentially via increased reactive oxygen species production.
  • MDR1a knockout protects against acute MDMA-induced changes in dopamine turnover.

Related Concept Videos